Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

18

Revenue 2017

Takeda

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Takeda's 2013 sales performance.

Takeda

FDA fast-tracks GSK’s anti-BCMA drug for multiple myeloma

FDA fast-tracks GSK’s anti-BCMA drug for multiple myeloma

The study participants had on average received seven earlier lines of therapy, including an immuno-modulatory drug such as Celgene’s Revlimid (lenalidomide), a proteasome inhibitor such as Takeda’s Velcade

Takeda’s subcutaneous Entyvio formulation faces FDA rejection

Takeda’s subcutaneous Entyvio formulation faces FDA rejection Was seeking approval in moderate-to-severe ulcerative colitis. A subcutaneous formulation of Takeda’s key growth product Entyvio has been rejected by the FDA, as a maintenance treatment for adults ... Takeda showcased a study of the intravenous

GSK files anti-BCMA drug for myeloma after second trial win

GSK files anti-BCMA drug for myeloma after second trial win Patients in the trial had on average received seven earlier lines of therapy, including an immuno-modulatory drug such as Celgene’s Revlimid (lenalidomide), a proteasome inhibitor such as Takeda’s

NINLARO Patient Support Programme

This entry from Takeda and Apodi was quite simply phenomenal! It is a fabulous patient support programme with good insight, clear and well measured objectives and successful outcomes. ... NINLARO Patient Support Programme - by Takeda UK and Ireland with

A Gut Reaction

Takeda executed a Medical and Educational Goods and Services Grant, which funded IQVIA project management leadership. ... A Gut Reaction - by Takeda UK and Ireland/Oxford University Hospital with support from IQVIA.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

White Paper for download - Explaining the price of your product
In this white paper, he breaks down the pricing options available to you, shares stories from his extensive experiences, and talks you through how to better define your pricing, step-by-step....
OPEN Health expands offering with the launch of a new Learning & Development specialist team
Enhanced expertise to deliver impactful internal training programmes for healthcare clients...
Figure 1 Clarivate
The changing nature of approvals – what does the future hold?
The 2019 CMR International Pharmaceutical R&D Factbook...

Infographics